|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
CHI's Strategies and Structures to Optimize R&D Performance | ||||||||||||||||
February 12, 2003 | ||||||||||||||||
Cambridge Healthtech Institute, Wyndham Franklin Plaza Hotel, 17th & Race Streets, Philadelphia, PA June 9-10, 2003 There are revolutionary changes happening in the pharmaceutical industry. Billions of dollars are at stake. Pharmaceutical companies must start investing resources to create an organizational structure that will support the new processes needed to reduce the time from target identification to clinical trials. Partial List of Confirmed Speakers Dr. Michael Liebman, Abramson Cancer Center of the University of Pennsylvania Arjun Bedi, Accenture Dr. Otto Ritter, AstraZeneca R&,D David Steward, Aventis SA John Murphy, CuraGen Dr. Rainer Fuchs, Biogen, Inc. Dr. Frank Wang, Boehringer Ingelheim Osagie O. Imasogie, GlaxoSmithKline Sven Blumenstiel, IBM Business Consulting Services Dr. Vanessa Lum, Johnson & Johnson Dr. Samuel Holtzman, Rosa Pharmaceuticals Dr. Jack Pollard, 3rd Millennium Inc. Dr. Alan Dunton
Pre-Conference Tutorial |
||||||||||||||||
Organized by: | Cambridge Healthtech Institute | |||||||||||||||
Invited Speakers: | Dr. Michael Liebman, Abramson Cancer Center of the University of Pennsylvania Arjun Bedi, Accenture Dr. Otto Ritter, AstraZeneca R&,D David Steward, Aventis SA John Murphy, CuraGen Dr. Rainer Fuchs, Biogen, Inc. Dr. Frank Wang, Boehringer Ingelheim Osagie O. Imasogie, GlaxoSmithKline Sven Blumenstiel, IBM Business Consulting Services Dr. Vanessa Lum, Johnson & Johnson Dr. Samuel Holtzman, Rosa Pharmaceuticals Dr. Jack Pollard, 3rd Millennium Inc. Dr. Alan Dunton |
|||||||||||||||
Deadline for Abstracts: | n/a | |||||||||||||||
Registration: | Available Online fax: 617-630-1325 call:617-630-1300 | |||||||||||||||
E-mail: | chi@healthtech.com | |||||||||||||||
Posted by: | elaine eskedal | |||||||||||||||
Host: | wks152.healthtech.com | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |